Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...

German biopharma company BioNTech has said it will commit up to £1 billion ($1.34 billion) in investment in the UK over the ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

Cambridge is set to become home to a major new research and development hub as part of a £1bn UK investment by biopharmaceutical firm BioNTech, expected to create more than 400 ...

As well as the economic and employment benefits, BioNTech’s UK investment is expected to deliver tangible improvements in healthcare. The company’s work in personalised cancer immunotherapies, already ...

Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer ...

BioNTech said it plans to invest up to 1 billion pounds ($1.34 billion) over the next 10 years to expand its research and development activities for innovative medicines in the U.K.

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed ...

BioNTech’s investment provides a template for UK growth, say ABPI The innovative biopharmaceutical company BioNTech has announced a major investment of up to £1bn over 10 years in the UK, potentially ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Rayner ‘urged Reeves’ to raise taxes on wealthy pensioners in secret memo - The chancellor has been adamant she will not turn ...

One thing we know about viruses is that they are bound to evolve and SARS-CoV-2, the virus that causes COVID-19, is no exception. Since the beginning of the pandemic, we have seen a number of its ...